PERCEPTIVE ADVISORS LLC Revance Therapeutics, Inc. Transaction History

PERCEPTIVE ADVISORS LLC portfolio value:

$21.83M
portfolio value

PERCEPTIVE ADVISORS LLC quarter portfolio value change:

+95.37%
quarter

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +41.25% 236.15K shares 13.92M $27 808.67K
Q2 2022 share Increase +316.33% 435K shares 5.23M $13.82 572.51K
Q1 2022 share Increase 0.00% 137.51K shares 2.68M $19.5 137.51K
Q3 2020 share Decrease -100.00% -65.83K shares -1.60M $25.14 0
Q2 2020 share Decrease -92.88% -859.16K shares -12.08M $24.42 65.83K
Q1 2020 share Increase +12.75% 104.62K shares 375K $14.8 925K
Q4 2019 share Increase 0.00% 820.37K shares 13.31M $16.23 820.37K
Q2 2018 share Decrease -100.00% -618.95K shares -19.06M $27.45 0
Q1 2018 share Increase +54.74% 218.95K shares 4.76M $30.8 618.95K
Q4 2017 share Increase 0.00% 400K shares 14.3M $35.75 400K